Turning Point Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in designing and developing novel small molecule targeted oncology therapies. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib (TPX-0005) is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+, NTRK+ or ALK+ advanced solid tumors. Its pipeline also includes multi-targeted drug candidates TPX-0046, a RET/SRC inhibitor; TPX-0022, a MET/CSF1R/SRC inhibitor; and a series of ALK inhibitors. The company was incorporated in 2013 and is headquartered in San Diego, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [11/08/2019 11:07 PST] Turning Point Therapeutics, Inc. (NASDAQ:TPTX), Up By 100.00% ($38.19) From $38.190 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [11/07/2019 12:23 PST] Turning Point Therapeutics, Inc. (NASDAQ:TPTX), Up By 100.00% ($36.55) From $36.550 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [11/07/2019 07:43 PST] TPTX Expected to Trade Up After Bullish Patterns Develop
• [11/05/2019 10:10 PST] TPTX SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [10/31/2019 07:46 PDT] TPTX Expected to Trade Up After Bullish Patterns Develop
• [10/24/2019 07:54 PDT] TPTX Expected to Trade Down Short Term
• [10/18/2019 07:51 PDT] TPTX Expected to Trade Up After Bullish Patterns Develop
• [09/30/2019 11:07 PDT] Turning Point Therapeutics, Inc. (NASDAQ:TPTX), Down By 100.00% ($39.57) From $39.570 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [09/27/2019 07:48 PDT] TPTX Expected to Trade Down Short Term
• [09/23/2019 07:58 PDT] TPTX Expected to Trade Down Short Term